MILLHAM, L. R., SCOTT, J. A., SAX, P. E., SHEBL, F. M., REDDY, K. P., LOSINA, E., . . . FREEDBERG, K. A. (2020). Clinical and economic impact of ibalizumab for people with multidrug-resistant HIV in the United States. J Acquir Immune Defic Syndr.
Citação norma ChicagoMILLHAM, Lucia R.I., Justine A. SCOTT, Paul E. SAX, Fatma M. SHEBL, Krishna P. REDDY, Elena LOSINA, Rochelle P. WALENSKY, and Kenneth A. FREEDBERG. "Clinical and Economic Impact of Ibalizumab for People With Multidrug-resistant HIV in the United States." J Acquir Immune Defic Syndr 2020.
Citação norma MLAMILLHAM, Lucia R.I., et al. "Clinical and Economic Impact of Ibalizumab for People With Multidrug-resistant HIV in the United States." J Acquir Immune Defic Syndr 2020.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.